"Category","Term","Genes","Count","List Total","Pop Hits","Pop Total","P-Value","Benjamini","Fold Enrichment","Bonferroni","FDR","Fisher Exact"
"REACTOME_PATHWAY","Signal Transduction","59.62%","62","104","2628","11494","1.80e-15","1.79e-12","2.61","1.76e-12","1.39e-12","6.67e-16"
"REACTOME_PATHWAY","PI3K/AKT Signaling in Cancer","15.38%","16","104","112","11494","5.19e-14","2.58e-11","15.79","5.16e-11","1.99e-11","2.85e-15"
"REACTOME_PATHWAY","Signaling by Receptor Tyrosine Kinases","26.92%","28","104","538","11494","1.14e-13","3.36e-11","5.75","1.13e-10","2.60e-11","1.89e-14"
"REACTOME_PATHWAY","PIP3 activates AKT signaling","20.19%","21","104","264","11494","1.53e-13","3.36e-11","8.79","1.52e-10","2.60e-11","1.62e-14"
"REACTOME_PATHWAY","Diseases of signal transduction by growth factor receptors and second messengers","25.00%","26","104","458","11494","1.69e-13","3.36e-11","6.27","1.68e-10","2.60e-11","2.56e-14"
"REACTOME_PATHWAY","Intracellular signaling by second messengers","21.15%","22","104","306","11494","2.44e-13","4.04e-11","7.95","2.43e-10","3.13e-11","2.87e-14"
"REACTOME_PATHWAY","Negative regulation of the PI3K/AKT network","14.42%","15","104","120","11494","2.66e-12","3.78e-10","13.81","2.64e-9","2.92e-10","1.71e-13"
"REACTOME_PATHWAY","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","13.46%","14","104","113","11494","2.03e-11","2.52e-9","13.69","2.01e-8","1.95e-9","1.32e-12"
"REACTOME_PATHWAY","Disease","45.19%","47","104","1926","11494","2.68e-11","2.96e-9","2.70","2.66e-8","2.29e-9","9.73e-12"
"REACTOME_PATHWAY","Constitutive Signaling by Aberrant PI3K in Cancer","11.54%","12","104","85","11494","2.14e-10","2.12e-8","15.60","2.12e-7","1.64e-8","1.20e-11"
"REACTOME_PATHWAY","Extra-nuclear estrogen signaling","10.58%","11","104","76","11494","1.25e-9","1.13e-7","16.00","1.24e-6","8.74e-8","6.82e-11"
"REACTOME_PATHWAY","VEGFA-VEGFR2 Pathway","10.58%","11","104","97","11494","1.41e-8","1.17e-6","12.53","1.40e-5","9.03e-7","1.01e-9"
"REACTOME_PATHWAY","MAPK family signaling cascades","16.35%","17","104","314","11494","1.72e-8","1.32e-6","5.98","1.71e-5","1.02e-6","2.73e-9"
"REACTOME_PATHWAY","MAPK1/MAPK3 signaling","15.38%","16","104","274","11494","1.94e-8","1.38e-6","6.45","1.93e-5","1.06e-6","2.84e-9"
"REACTOME_PATHWAY","Signaling by Interleukins","19.23%","20","104","471","11494","3.06e-8","2.03e-6","4.69","3.04e-5","1.57e-6","6.25e-9"
"REACTOME_PATHWAY","Hemostasis","23.08%","24","104","699","11494","3.93e-8","2.34e-6","3.79","3.90e-5","1.81e-6","1.00e-8"
"REACTOME_PATHWAY","Signaling by VEGF","10.58%","11","104","108","11494","4.01e-8","2.34e-6","11.26","3.98e-5","1.81e-6","3.24e-9"
"REACTOME_PATHWAY","CD28 dependent PI3K/Akt signaling","6.73%","7","104","27","11494","1.14e-7","6.27e-6","28.65","1.13e-4","4.85e-6","3.10e-9"
"REACTOME_PATHWAY","Co-stimulation by CD28","7.69%","8","104","47","11494","1.77e-7","9.16e-6","18.81","1.76e-4","7.09e-6","8.04e-9"
"REACTOME_PATHWAY","GPCR downstream signalling","21.15%","22","104","641","11494","1.85e-7","9.16e-6","3.79","1.83e-4","7.09e-6","4.69e-8"
"REACTOME_PATHWAY","Signaling by GPCR","22.12%","23","104","716","11494","2.72e-7","1.29e-5","3.55","2.70e-4","9.94e-6","7.40e-8"
"REACTOME_PATHWAY","Signaling by NTRKs","10.58%","11","104","133","11494","2.90e-7","1.31e-5","9.14","2.88e-4","1.01e-5","2.94e-8"
"REACTOME_PATHWAY","Cellular responses to stimuli","25.00%","26","104","919","11494","3.61e-7","1.56e-5","3.13","3.58e-4","1.21e-5","1.12e-7"
"REACTOME_PATHWAY","MAPK1 (ERK2) activation","4.81%","5","104","8","11494","4.14e-7","1.71e-5","69.07","4.11e-4","1.33e-5","3.02e-9"
"REACTOME_PATHWAY","Regulation of T cell activation by CD28 family","8.65%","9","104","82","11494","6.51e-7","2.59e-5","12.13","6.47e-4","2.00e-5","4.85e-8"
"REACTOME_PATHWAY","ESR-mediated signaling","12.50%","13","104","223","11494","6.84e-7","2.61e-5","6.44","6.79e-4","2.02e-5","1.00e-7"
"REACTOME_PATHWAY","MAPK3 (ERK1) activation","4.81%","5","104","9","11494","7.40e-7","2.72e-5","61.40","7.35e-4","2.11e-5","6.74e-9"
"REACTOME_PATHWAY","RAF/MAP kinase cascade","13.46%","14","104","269","11494","7.74e-7","2.75e-5","5.75","7.68e-4","2.12e-5","1.28e-7"
"REACTOME_PATHWAY","RAF-independent MAPK1/3 activation","5.77%","6","104","22","11494","1.22e-6","4.19e-5","30.14","1.21e-3","3.24e-5","3.15e-8"
"REACTOME_PATHWAY","Axon guidance","18.27%","19","104","544","11494","1.38e-6","4.57e-5","3.86","1.37e-3","3.53e-5","3.44e-7"
"REACTOME_PATHWAY","Cytokine Signaling in Immune system","22.12%","23","104","801","11494","1.81e-6","5.80e-5","3.17","1.80e-3","4.49e-5","5.53e-7"
"REACTOME_PATHWAY","Neurotransmitter clearance","4.81%","5","104","11","11494","1.91e-6","5.93e-5","50.24","1.90e-3","4.59e-5","2.44e-8"
"REACTOME_PATHWAY","Signaling by Nuclear Receptors","13.46%","14","104","297","11494","2.35e-6","7.00e-5","5.21","2.33e-3","5.41e-5","4.29e-7"
"REACTOME_PATHWAY","Interleukin-2 family signaling","6.73%","7","104","44","11494","2.40e-6","7.00e-5","17.58","2.38e-3","5.41e-5","1.18e-7"
"REACTOME_PATHWAY","Nervous system development","18.27%","19","104","569","11494","2.62e-6","7.42e-5","3.69","2.59e-3","5.74e-5","6.83e-7"
"REACTOME_PATHWAY","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","4.81%","5","104","12","11494","2.85e-6","7.86e-5","46.05","2.83e-3","6.08e-5","4.15e-8"
"REACTOME_PATHWAY","Interleukin receptor SHC signaling","5.77%","6","104","27","11494","3.62e-6","9.71e-5","24.56","3.59e-3","7.51e-5","1.20e-7"
"REACTOME_PATHWAY","Platelet activation, signaling and aggregation","12.50%","13","104","266","11494","4.34e-6","1.13e-4","5.40","4.30e-3","8.77e-5","7.63e-7"
"REACTOME_PATHWAY","Interleukin-3, Interleukin-5 and GM-CSF signaling","6.73%","7","104","50","11494","5.16e-6","1.31e-4","15.47","5.11e-3","1.02e-4","2.94e-7"
"REACTOME_PATHWAY","Nuclear Receptor transcription pathway","6.73%","7","104","52","11494","6.52e-6","1.58e-4","14.88","6.45e-3","1.22e-4","3.88e-7"
"REACTOME_PATHWAY","Insulin receptor signalling cascade","6.73%","7","104","52","11494","6.52e-6","1.58e-4","14.88","6.45e-3","1.22e-4","3.88e-7"
"REACTOME_PATHWAY","Interleukin-4 and Interleukin-13 signaling","8.65%","9","104","112","11494","6.97e-6","1.62e-4","8.88","6.90e-3","1.25e-4","7.27e-7"
"REACTOME_PATHWAY","Signaling by Insulin receptor","7.69%","8","104","80","11494","7.02e-6","1.62e-4","11.05","6.95e-3","1.25e-4","5.79e-7"
"REACTOME_PATHWAY","Signaling by NTRK1 (TRKA)","8.65%","9","104","114","11494","7.95e-6","1.79e-4","8.73","7.86e-3","1.39e-4","8.45e-7"
"REACTOME_PATHWAY","Regulation of TP53 Activity","9.62%","10","104","161","11494","1.35e-5","2.99e-4","6.86","1.33e-2","2.31e-4","1.85e-6"
"REACTOME_PATHWAY","GPVI-mediated activation cascade","5.77%","6","104","36","11494","1.58e-5","3.42e-4","18.42","1.56e-2","2.65e-4","7.42e-7"
"REACTOME_PATHWAY","Regulation of TP53 Activity through Phosphorylation","7.69%","8","104","92","11494","1.77e-5","3.75e-4","9.61","1.75e-2","2.90e-4","1.70e-6"
"REACTOME_PATHWAY","Signaling by LTK in cancer","3.85%","4","104","7","11494","2.38e-5","4.93e-4","63.15","2.34e-2","3.81e-4","2.17e-7"
"REACTOME_PATHWAY","Signal transduction by L1","4.81%","5","104","20","11494","2.64e-5","5.35e-4","27.63","2.59e-2","4.14e-4","7.66e-7"
"REACTOME_PATHWAY","Generic Transcription Pathway","25.96%","27","104","1267","11494","3.68e-5","7.21e-4","2.36","3.59e-2","5.58e-4","1.52e-5"
"REACTOME_PATHWAY","Cellular responses to mechanical stimuli","7.69%","8","104","103","11494","3.70e-5","7.21e-4","8.58","3.61e-2","5.58e-4","4.00e-6"
"REACTOME_PATHWAY","IFNG signaling activates MAPKs","3.85%","4","104","8","11494","3.79e-5","7.23e-4","55.26","3.69e-2","5.59e-4","4.31e-7"
"REACTOME_PATHWAY","Transcriptional regulation by RUNX2","7.69%","8","104","107","11494","4.73e-5","8.87e-4","8.26","4.59e-2","6.86e-4","5.33e-6"
"REACTOME_PATHWAY","Phase I - Functionalization of compounds","7.69%","8","104","109","11494","5.33e-5","9.80e-4","8.11","5.15e-2","7.58e-4","6.12e-6"
"REACTOME_PATHWAY","RUNX2 regulates osteoblast differentiation","4.81%","5","104","24","11494","5.63e-5","9.83e-4","23.02","5.44e-2","7.61e-4","2.04e-6"
"REACTOME_PATHWAY","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","4.81%","5","104","24","11494","5.63e-5","9.83e-4","23.02","5.44e-2","7.61e-4","2.04e-6"
"REACTOME_PATHWAY","Biosynthesis of maresins","3.85%","4","104","9","11494","5.65e-5","9.83e-4","49.12","5.45e-2","7.61e-4","7.70e-7"
"REACTOME_PATHWAY","Fcgamma receptor (FCGR) dependent phagocytosis","8.65%","9","104","152","11494","6.40e-5","1.10e-3","6.54","6.16e-2","8.47e-4","9.20e-6"
"REACTOME_PATHWAY","Interleukin-20 family signaling","4.81%","5","104","25","11494","6.66e-5","1.10e-3","22.10","6.40e-2","8.52e-4","2.53e-6"
"REACTOME_PATHWAY","Signaling by Erythropoietin","4.81%","5","104","25","11494","6.66e-5","1.10e-3","22.10","6.40e-2","8.52e-4","2.53e-6"
"REACTOME_PATHWAY","Activation of the AP-1 family of transcription factors","3.85%","4","104","10","11494","8.01e-5","1.30e-3","44.21","7.65e-2","1.01e-3","1.27e-6"
"REACTOME_PATHWAY","Interleukin-6 signaling","3.85%","4","104","11","11494","1.09e-4","1.75e-3","40.19","1.03e-1","1.36e-3","1.99e-6"
"REACTOME_PATHWAY","Metabolism of lipids","18.27%","19","104","760","11494","1.27e-4","2.00e-3","2.76","1.19e-1","1.55e-3","4.43e-5"
"REACTOME_PATHWAY","Co-stimulation by ICOS","3.85%","4","104","12","11494","1.45e-4","2.21e-3","36.84","1.34e-1","1.71e-3","2.96e-6"
"REACTOME_PATHWAY","Frs2-mediated activation","3.85%","4","104","12","11494","1.45e-4","2.21e-3","36.84","1.34e-1","1.71e-3","2.96e-6"
"REACTOME_PATHWAY","Signaling by ALK in cancer","6.73%","7","104","90","11494","1.52e-4","2.25e-3","8.60","1.40e-1","1.74e-3","1.64e-5"
"REACTOME_PATHWAY","Signaling by ALK fusions and activated point mutants","6.73%","7","104","90","11494","1.52e-4","2.25e-3","8.60","1.40e-1","1.74e-3","1.64e-5"
"REACTOME_PATHWAY","Signaling by CSF1 (M-CSF) in myeloid cells","4.81%","5","104","31","11494","1.59e-4","2.28e-3","17.83","1.46e-1","1.77e-3","7.76e-6"
"REACTOME_PATHWAY","MAPK targets/ Nuclear events mediated by MAP kinases","4.81%","5","104","31","11494","1.59e-4","2.28e-3","17.83","1.46e-1","1.77e-3","7.76e-6"
"REACTOME_PATHWAY","Cellular response to heat stress","6.73%","7","104","91","11494","1.61e-4","2.28e-3","8.50","1.48e-1","1.77e-3","1.76e-5"
"REACTOME_PATHWAY","RNA Polymerase II Transcription","25.96%","27","104","1390","11494","1.74e-4","2.43e-3","2.15","1.59e-1","1.88e-3","7.86e-5"
"REACTOME_PATHWAY","RHO GTPase Effectors","11.54%","12","104","331","11494","1.79e-4","2.44e-3","4.01","1.63e-1","1.88e-3","4.28e-5"
"REACTOME_PATHWAY","RUNX2 regulates bone development","4.81%","5","104","32","11494","1.80e-4","2.44e-3","17.27","1.64e-1","1.88e-3","9.13e-6"
"REACTOME_PATHWAY","Response of endothelial cells to shear stress","6.73%","7","104","93","11494","1.82e-4","2.44e-3","8.32","1.65e-1","1.88e-3","2.03e-5"
"REACTOME_PATHWAY","Signalling to ERKs","4.81%","5","104","33","11494","2.04e-4","2.70e-3","16.75","1.83e-1","2.09e-3","1.07e-5"
"REACTOME_PATHWAY","Infectious disease","22.12%","23","104","1094","11494","2.26e-4","2.95e-3","2.32","2.01e-1","2.28e-3","9.39e-5"
"REACTOME_PATHWAY","Prolonged ERK activation events","3.85%","4","104","14","11494","2.37e-4","3.05e-3","31.58","2.10e-1","2.36e-3","5.91e-6"
"REACTOME_PATHWAY","Cellular responses to stress","18.27%","19","104","808","11494","2.72e-4","3.46e-3","2.60","2.37e-1","2.68e-3","1.01e-4"
"REACTOME_PATHWAY","RHO GTPases Activate WASPs and WAVEs","4.81%","5","104","36","11494","2.87e-4","3.57e-3","15.35","2.48e-1","2.76e-3","1.66e-5"
"REACTOME_PATHWAY","Regulation of TP53 Degradation","4.81%","5","104","36","11494","2.87e-4","3.57e-3","15.35","2.48e-1","2.76e-3","1.66e-5"
"REACTOME_PATHWAY","Spry regulation of FGF signaling","3.85%","4","104","15","11494","2.94e-4","3.60e-3","29.47","2.53e-1","2.79e-3","8.00e-6"
"REACTOME_PATHWAY","Regulation of TP53 Expression and Degradation","4.81%","5","104","37","11494","3.20e-4","3.88e-3","14.94","2.72e-1","3.00e-3","1.91e-5"
"REACTOME_PATHWAY","Gene expression (Transcription)","27.88%","29","104","1614","11494","3.29e-4","3.94e-3","1.99","2.79e-1","3.04e-3","1.61e-4"
"REACTOME_PATHWAY","FLT3 Signaling","4.81%","5","104","38","11494","3.55e-4","4.15e-3","14.54","2.97e-1","3.21e-3","2.18e-5"
"REACTOME_PATHWAY","Signaling by FGFR3","4.81%","5","104","38","11494","3.55e-4","4.15e-3","14.54","2.97e-1","3.21e-3","2.18e-5"
"REACTOME_PATHWAY","Developmental Biology","25.96%","27","104","1457","11494","3.70e-4","4.27e-3","2.05","3.07e-1","3.30e-3","1.75e-4"
"REACTOME_PATHWAY","Cell Cycle","16.35%","17","104","687","11494","3.80e-4","4.34e-3","2.73","3.15e-1","3.36e-3","1.34e-4"
"REACTOME_PATHWAY","Signaling by FGFR4","4.81%","5","104","39","11494","3.93e-4","4.44e-3","14.17","3.23e-1","3.43e-3","2.48e-5"
"REACTOME_PATHWAY","GAB1 signalosome","3.85%","4","104","17","11494","4.34e-4","4.79e-3","26.00","3.50e-1","3.70e-3","1.38e-5"
"REACTOME_PATHWAY","RET signaling","4.81%","5","104","40","11494","4.34e-4","4.79e-3","13.81","3.50e-1","3.70e-3","2.82e-5"
"REACTOME_PATHWAY","Immune System","33.65%","35","104","2177","11494","4.59e-4","5.01e-3","1.78","3.66e-1","3.87e-3","2.51e-4"
"REACTOME_PATHWAY","MITF-M-regulated melanocyte development","7.69%","8","104","155","11494","4.75e-4","5.13e-3","5.70","3.76e-1","3.97e-3","7.87e-5"
"REACTOME_PATHWAY","Biosynthesis of DHA-derived SPMs","3.85%","4","104","18","11494","5.17e-4","5.46e-3","24.56","4.02e-1","4.23e-3","1.76e-5"
"REACTOME_PATHWAY","Gastrin-CREB signalling pathway via PKC and MAPK","3.85%","4","104","18","11494","5.17e-4","5.46e-3","24.56","4.02e-1","4.23e-3","1.76e-5"
"REACTOME_PATHWAY","PI3K Cascade","4.81%","5","104","42","11494","5.24e-4","5.48e-3","13.16","4.06e-1","4.24e-3","3.59e-5"
"REACTOME_PATHWAY","G alpha (s) signalling events","7.69%","8","104","158","11494","5.33e-4","5.52e-3","5.60","4.11e-1","4.27e-3","9.00e-5"
"REACTOME_PATHWAY","Bacterial Infection Pathways","5.77%","6","104","75","11494","5.50e-4","5.63e-3","8.84","4.21e-1","4.36e-3","5.77e-5"
"REACTOME_PATHWAY","Signaling by RAF1 mutants","4.81%","5","104","43","11494","5.74e-4","5.81e-3","12.85","4.34e-1","4.50e-3","4.03e-5"
"REACTOME_PATHWAY","Signaling by Rho GTPases","16.35%","17","104","716","11494","5.99e-4","6.01e-3","2.62","4.48e-1","4.65e-3","2.20e-4"
"REACTOME_PATHWAY","Potential therapeutics for SARS","7.69%","8","104","165","11494","6.91e-4","6.86e-3","5.36","4.96e-1","5.30e-3","1.22e-4"
"REACTOME_PATHWAY","Biosynthesis of specialized proresolving mediators (SPMs)","3.85%","4","104","20","11494","7.13e-4","7.01e-3","22.10","5.08e-1","5.42e-3","2.74e-5"
"REACTOME_PATHWAY","IRS-mediated signalling","4.81%","5","104","46","11494","7.43e-4","7.24e-3","12.01","5.22e-1","5.60e-3","5.62e-5"
"REACTOME_PATHWAY","Signaling by Rho GTPases, Miro GTPases and RHOBTB3","16.35%","17","104","732","11494","7.61e-4","7.33e-3","2.57","5.30e-1","5.67e-3","2.85e-4"
"REACTOME_PATHWAY","G alpha (q) signalling events","8.65%","9","104","219","11494","7.70e-4","7.35e-3","4.54","5.35e-1","5.68e-3","1.61e-4"
"REACTOME_PATHWAY","Signaling downstream of RAS mutants","4.81%","5","104","47","11494","8.07e-4","7.42e-3","11.76","5.51e-1","5.74e-3","6.25e-5"
"REACTOME_PATHWAY","Signaling by moderate kinase activity BRAF mutants","4.81%","5","104","47","11494","8.07e-4","7.42e-3","11.76","5.51e-1","5.74e-3","6.25e-5"
"REACTOME_PATHWAY","Signaling by RAS mutants","4.81%","5","104","47","11494","8.07e-4","7.42e-3","11.76","5.51e-1","5.74e-3","6.25e-5"
"REACTOME_PATHWAY","Paradoxical activation of RAF signaling by kinase inactive BRAF","4.81%","5","104","47","11494","8.07e-4","7.42e-3","11.76","5.51e-1","5.74e-3","6.25e-5"
"REACTOME_PATHWAY","Transmission across Chemical Synapses","9.62%","10","104","278","11494","8.58e-4","7.81e-3","3.98","5.73e-1","6.04e-3","2.05e-4"
"REACTOME_PATHWAY","Signaling by FGFR1","4.81%","5","104","49","11494","9.46e-4","8.51e-3","11.28","6.09e-1","6.58e-3","7.65e-5"
"REACTOME_PATHWAY","ERK/MAPK targets","3.85%","4","104","22","11494","9.51e-4","8.51e-3","20.09","6.11e-1","6.58e-3","4.08e-5"
"REACTOME_PATHWAY","PTEN Regulation","6.73%","7","104","128","11494","1.00e-3","8.81e-3","6.04","6.31e-1","6.82e-3","1.56e-4"
"REACTOME_PATHWAY","Regulation of actin dynamics for phagocytic cup formation","6.73%","7","104","128","11494","1.00e-3","8.81e-3","6.04","6.31e-1","6.82e-3","1.56e-4"
"REACTOME_PATHWAY","IGF1R signaling cascade","4.81%","5","104","50","11494","1.02e-3","8.81e-3","11.05","6.37e-1","6.82e-3","8.44e-5"
"REACTOME_PATHWAY","IRS-related events triggered by IGF1R","4.81%","5","104","50","11494","1.02e-3","8.81e-3","11.05","6.37e-1","6.82e-3","8.44e-5"
"REACTOME_PATHWAY","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","4.81%","5","104","51","11494","1.10e-3","9.34e-3","10.84","6.65e-1","7.22e-3","9.29e-5"
"REACTOME_PATHWAY","Signaling by ERBB2","4.81%","5","104","51","11494","1.10e-3","9.34e-3","10.84","6.65e-1","7.22e-3","9.29e-5"
"REACTOME_PATHWAY","Negative feedback regulation of MAPK pathway","2.88%","3","104","6","11494","1.17e-3","9.81e-3","55.26","6.86e-1","7.58e-3","1.41e-5"
"REACTOME_PATHWAY","Interleukin-6 family signaling","3.85%","4","104","24","11494","1.23e-3","1.03e-2","18.42","7.06e-1","7.96e-3","5.85e-5"
"REACTOME_PATHWAY","Cell Cycle, Mitotic","13.46%","14","104","554","11494","1.31e-3","1.08e-2","2.79","7.28e-1","8.39e-3","4.49e-4"
"REACTOME_PATHWAY","RHO GTPases Activate NADPH Oxidases","3.85%","4","104","25","11494","1.39e-3","1.14e-2","17.68","7.49e-1","8.84e-3","6.91e-5"
"REACTOME_PATHWAY","Constitutive Signaling by AKT1 E17K in Cancer","3.85%","4","104","26","11494","1.56e-3","1.27e-2","17.00","7.89e-1","9.85e-3","8.11e-5"
"REACTOME_PATHWAY","RSK activation","2.88%","3","104","7","11494","1.62e-3","1.31e-2","47.37","8.00e-1","1.01e-2","2.45e-5"
"REACTOME_PATHWAY","SUMOylation of intracellular receptors","3.85%","4","104","27","11494","1.75e-3","1.40e-2","16.37","8.24e-1","1.08e-2","9.46e-5"
"REACTOME_PATHWAY","Negative regulation of FGFR3 signaling","3.85%","4","104","28","11494","1.95e-3","1.55e-2","15.79","8.55e-1","1.20e-2","1.10e-4"
"REACTOME_PATHWAY","Arachidonate metabolism","4.81%","5","104","60","11494","2.02e-3","1.59e-2","9.21","8.66e-1","1.23e-2","2.03e-4"
"REACTOME_PATHWAY","Toll Like Receptor 4 (TLR4) Cascade","6.73%","7","104","147","11494","2.04e-3","1.60e-2","5.26","8.69e-1","1.23e-2","3.66e-4"
"REACTOME_PATHWAY","NCAM signaling for neurite out-growth","4.81%","5","104","61","11494","2.15e-3","1.60e-2","9.06","8.81e-1","1.24e-2","2.19e-4"
"REACTOME_PATHWAY","Suppression of apoptosis","2.88%","3","104","8","11494","2.15e-3","1.60e-2","41.44","8.82e-1","1.24e-2","3.90e-5"
"REACTOME_PATHWAY","Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)","2.88%","3","104","8","11494","2.15e-3","1.60e-2","41.44","8.82e-1","1.24e-2","3.90e-5"
"REACTOME_PATHWAY","Signaling by ALK","3.85%","4","104","29","11494","2.16e-3","1.60e-2","15.24","8.83e-1","1.24e-2","1.26e-4"
"REACTOME_PATHWAY","Downstream signal transduction","3.85%","4","104","29","11494","2.16e-3","1.60e-2","15.24","8.83e-1","1.24e-2","1.26e-4"
"REACTOME_PATHWAY","VEGFR2 mediated vascular permeability","3.85%","4","104","29","11494","2.16e-3","1.60e-2","15.24","8.83e-1","1.24e-2","1.26e-4"
"REACTOME_PATHWAY","DAP12 signaling","3.85%","4","104","29","11494","2.16e-3","1.60e-2","15.24","8.83e-1","1.24e-2","1.26e-4"
"REACTOME_PATHWAY","Regulation of PTEN gene transcription","4.81%","5","104","62","11494","2.28e-3","1.68e-2","8.91","8.96e-1","1.30e-2","2.37e-4"
"REACTOME_PATHWAY","Signaling by CSF3 (G-CSF)","3.85%","4","104","30","11494","2.38e-3","1.73e-2","14.74","9.06e-1","1.33e-2","1.45e-4"
"REACTOME_PATHWAY","Negative regulation of FGFR4 signaling","3.85%","4","104","30","11494","2.38e-3","1.73e-2","14.74","9.06e-1","1.33e-2","1.45e-4"
"REACTOME_PATHWAY","MAP kinase activation","4.81%","5","104","63","11494","2.42e-3","1.74e-2","8.77","9.09e-1","1.34e-2","2.55e-4"
"REACTOME_PATHWAY","Negative regulation of FGFR1 signaling","3.85%","4","104","31","11494","2.62e-3","1.87e-2","14.26","9.26e-1","1.45e-2","1.65e-4"
"REACTOME_PATHWAY","Innate Immune System","20.19%","21","104","1150","11494","2.74e-3","1.94e-2","2.02","9.34e-1","1.50e-2","1.31e-3"
"REACTOME_PATHWAY","PI3K/AKT activation","2.88%","3","104","9","11494","2.75e-3","1.94e-2","36.84","9.35e-1","1.50e-2","5.81e-5"
"REACTOME_PATHWAY","G-protein beta:gamma signalling","3.85%","4","104","32","11494","2.87e-3","1.99e-2","13.81","9.42e-1","1.54e-2","1.87e-4"
"REACTOME_PATHWAY","Negative regulation of FGFR2 signaling","3.85%","4","104","32","11494","2.87e-3","1.99e-2","13.81","9.42e-1","1.54e-2","1.87e-4"
"REACTOME_PATHWAY","Signaling by BRAF and RAF1 fusions","4.81%","5","104","67","11494","3.02e-3","2.09e-2","8.25","9.51e-1","1.61e-2","3.41e-4"
"REACTOME_PATHWAY","Phospholipid metabolism","7.69%","8","104","214","11494","3.08e-3","2.11e-2","4.13","9.53e-1","1.63e-2","7.06e-4"
"REACTOME_PATHWAY","MyD88-independent TLR4 cascade","5.77%","6","104","111","11494","3.17e-3","2.14e-2","5.97","9.57e-1","1.66e-2","4.99e-4"
"REACTOME_PATHWAY","TRIF (TICAM1)-mediated TLR4 signaling","5.77%","6","104","111","11494","3.17e-3","2.14e-2","5.97","9.57e-1","1.66e-2","4.99e-4"
"REACTOME_PATHWAY","Cytochrome P450 - arranged by substrate type","4.81%","5","104","68","11494","3.19e-3","2.14e-2","8.13","9.58e-1","1.66e-2","3.65e-4"
"REACTOME_PATHWAY","Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus","2.88%","3","104","10","11494","3.41e-3","2.25e-2","33.16","9.67e-1","1.74e-2","8.25e-5"
"REACTOME_PATHWAY","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5.77%","6","104","113","11494","3.42e-3","2.25e-2","5.87","9.67e-1","1.74e-2","5.49e-4"
"REACTOME_PATHWAY","Toll Like Receptor TLR6:TLR2 Cascade","5.77%","6","104","113","11494","3.42e-3","2.25e-2","5.87","9.67e-1","1.74e-2","5.49e-4"
"REACTOME_PATHWAY","Signaling by FGFR2","4.81%","5","104","70","11494","3.55e-3","2.32e-2","7.89","9.71e-1","1.79e-2","4.18e-4"
"REACTOME_PATHWAY","Regulation of HSF1-mediated heat shock response","4.81%","5","104","71","11494","3.73e-3","2.39e-2","7.78","9.76e-1","1.85e-2","4.46e-4"
"REACTOME_PATHWAY","Interleukin-17 signaling","4.81%","5","104","71","11494","3.73e-3","2.39e-2","7.78","9.76e-1","1.85e-2","4.46e-4"
"REACTOME_PATHWAY","High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells","4.81%","5","104","71","11494","3.73e-3","2.39e-2","7.78","9.76e-1","1.85e-2","4.46e-4"
"REACTOME_PATHWAY","Toll Like Receptor TLR1:TLR2 Cascade","5.77%","6","104","116","11494","3.83e-3","2.42e-2","5.72","9.78e-1","1.87e-2","6.30e-4"
"REACTOME_PATHWAY","Toll Like Receptor 2 (TLR2) Cascade","5.77%","6","104","116","11494","3.83e-3","2.42e-2","5.72","9.78e-1","1.87e-2","6.30e-4"
"REACTOME_PATHWAY","SARS-CoV Infections","11.54%","12","104","484","11494","3.98e-3","2.50e-2","2.74","9.81e-1","1.94e-2","1.38e-3"
"REACTOME_PATHWAY","Signaling by high-kinase activity BRAF mutants","3.85%","4","104","36","11494","4.03e-3","2.51e-2","12.28","9.82e-1","1.94e-2","2.98e-4"
"REACTOME_PATHWAY","Interleukin-27 signaling","2.88%","3","104","11","11494","4.15e-3","2.54e-2","30.14","9.84e-1","1.97e-2","1.13e-4"
"REACTOME_PATHWAY","Removal of aminoterminal propeptides from gamma-carboxylated proteins","2.88%","3","104","11","11494","4.15e-3","2.54e-2","30.14","9.84e-1","1.97e-2","1.13e-4"
"REACTOME_PATHWAY","Gamma-carboxylation of protein precursors","2.88%","3","104","11","11494","4.15e-3","2.54e-2","30.14","9.84e-1","1.97e-2","1.13e-4"
"REACTOME_PATHWAY","Biological oxidations","7.69%","8","104","228","11494","4.36e-3","2.66e-2","3.88","9.87e-1","2.05e-2","1.06e-3"
"REACTOME_PATHWAY","Toll-like Receptor Cascades","6.73%","7","104","172","11494","4.45e-3","2.69e-2","4.50","9.88e-1","2.08e-2","9.34e-4"
"REACTOME_PATHWAY","APC/C-mediated degradation of cell cycle proteins","4.81%","5","104","75","11494","4.54e-3","2.72e-2","7.37","9.89e-1","2.10e-2","5.75e-4"
"REACTOME_PATHWAY","Regulation of mitotic cell cycle","4.81%","5","104","75","11494","4.54e-3","2.72e-2","7.37","9.89e-1","2.10e-2","5.75e-4"
"REACTOME_PATHWAY","DNA Double-Strand Break Repair","6.73%","7","104","173","11494","4.58e-3","2.72e-2","4.47","9.89e-1","2.10e-2","9.67e-4"
"REACTOME_PATHWAY","L1CAM interactions","5.77%","6","104","123","11494","4.92e-3","2.87e-2","5.39","9.92e-1","2.22e-2","8.58e-4"
"REACTOME_PATHWAY","Gamma-carboxylation, transport, and amino-terminal cleavage of proteins","2.88%","3","104","12","11494","4.95e-3","2.87e-2","27.63","9.93e-1","2.22e-2","1.49e-4"
"REACTOME_PATHWAY","Interleukin-35 Signalling","2.88%","3","104","12","11494","4.95e-3","2.87e-2","27.63","9.93e-1","2.22e-2","1.49e-4"
"REACTOME_PATHWAY","Interleukin-2 signaling","2.88%","3","104","12","11494","4.95e-3","2.87e-2","27.63","9.93e-1","2.22e-2","1.49e-4"
"REACTOME_PATHWAY","Transcriptional Regulation by TP53","9.62%","10","104","361","11494","5.04e-3","2.91e-2","3.06","9.93e-1","2.25e-2","1.56e-3"
"REACTOME_PATHWAY","MAP2K and MAPK activation","3.85%","4","104","40","11494","5.43e-3","3.12e-2","11.05","9.96e-1","2.41e-2","4.50e-4"
"REACTOME_PATHWAY","Signaling by MET","4.81%","5","104","80","11494","5.71e-3","3.26e-2","6.91","9.97e-1","2.52e-2","7.73e-4"
"REACTOME_PATHWAY","Regulation of IFNG signaling","2.88%","3","104","13","11494","5.82e-3","3.28e-2","25.50","9.97e-1","2.54e-2","1.93e-4"
"REACTOME_PATHWAY","Formation of Fibrin Clot (Clotting Cascade)","3.85%","4","104","41","11494","5.82e-3","3.28e-2","10.78","9.97e-1","2.54e-2","4.95e-4"
"REACTOME_PATHWAY","Fc epsilon receptor (FCERI) signaling","6.73%","7","104","184","11494","6.16e-3","3.45e-2","4.20","9.98e-1","2.67e-2","1.38e-3"
"REACTOME_PATHWAY","Signaling by SCF-KIT","3.85%","4","104","43","11494","6.65e-3","3.71e-2","10.28","9.99e-1","2.87e-2","5.95e-4"
"REACTOME_PATHWAY","AKT phosphorylates targets in the cytosol","2.88%","3","104","14","11494","6.75e-3","3.72e-2","23.68","9.99e-1","2.88e-2","2.44e-4"
"REACTOME_PATHWAY","Golgi Cisternae Pericentriolar Stack Reorganization","2.88%","3","104","14","11494","6.75e-3","3.72e-2","23.68","9.99e-1","2.88e-2","2.44e-4"
"REACTOME_PATHWAY","Oncogenic MAPK signaling","4.81%","5","104","84","11494","6.78e-3","3.72e-2","6.58","9.99e-1","2.88e-2","9.65e-4"
"REACTOME_PATHWAY","Signaling by FGFR","4.81%","5","104","85","11494","7.07e-3","3.85e-2","6.50","9.99e-1","2.98e-2","1.02e-3"
"REACTOME_PATHWAY","Aspirin ADME","3.85%","4","104","44","11494","7.09e-3","3.85e-2","10.05","9.99e-1","2.98e-2","6.50e-4"
"REACTOME_PATHWAY","Signaling by EGFRvIII in Cancer","2.88%","3","104","15","11494","7.74e-3","4.15e-2","22.10","1.00e+0","3.21e-2","3.03e-4"
"REACTOME_PATHWAY","Constitutive Signaling by EGFRvIII","2.88%","3","104","15","11494","7.74e-3","4.15e-2","22.10","1.00e+0","3.21e-2","3.03e-4"
"REACTOME_PATHWAY","Smooth Muscle Contraction","3.85%","4","104","46","11494","8.02e-3","4.28e-2","9.61","1.00e+0","3.31e-2","7.71e-4"
"REACTOME_PATHWAY","Platelet homeostasis","4.81%","5","104","89","11494","8.30e-3","4.41e-2","6.21","1.00e+0","3.41e-2","1.25e-3"
"REACTOME_PATHWAY","Cellular Senescence","6.73%","7","104","198","11494","8.70e-3","4.57e-2","3.91","1.00e+0","3.54e-2","2.10e-3"
"REACTOME_PATHWAY","Signaling by ERBB2 ECD mutants","2.88%","3","104","16","11494","8.79e-3","4.57e-2","20.72","1.00e+0","3.54e-2","3.70e-4"
"REACTOME_PATHWAY","cGMP effects","2.88%","3","104","16","11494","8.79e-3","4.57e-2","20.72","1.00e+0","3.54e-2","3.70e-4"
"REACTOME_PATHWAY","Signaling by FLT3 ITD and TKD mutants","2.88%","3","104","16","11494","8.79e-3","4.57e-2","20.72","1.00e+0","3.54e-2","3.70e-4"
"REACTOME_PATHWAY","Programmed Cell Death","6.73%","7","104","199","11494","8.91e-3","4.61e-2","3.89","1.00e+0","3.56e-2","2.16e-3"
"REACTOME_PATHWAY","Opioid Signalling","4.81%","5","104","92","11494","9.30e-3","4.79e-2","6.01","1.00e+0","3.70e-2","1.45e-3"
"REACTOME_PATHWAY","Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)","2.88%","3","104","17","11494","9.91e-3","5.05e-2","19.50","1.00e+0","3.90e-2","4.46e-4"
"REACTOME_PATHWAY","IL-6-type cytokine receptor ligand interactions","2.88%","3","104","17","11494","9.91e-3","5.05e-2","19.50","1.00e+0","3.90e-2","4.46e-4"
"REACTOME_PATHWAY","Interleukin-12 signaling","3.85%","4","104","50","11494","1.01e-2","5.12e-2","8.84","1.00e+0","3.96e-2","1.06e-3"
"REACTOME_PATHWAY","DAP12 interactions","3.85%","4","104","51","11494","1.07e-2","5.37e-2","8.67","1.00e+0","4.16e-2","1.14e-3"
"REACTOME_PATHWAY","Tie2 Signaling","2.88%","3","104","18","11494","1.11e-2","5.48e-2","18.42","1.00e+0","4.24e-2","5.32e-4"
"REACTOME_PATHWAY","Toll Like Receptor 10 (TLR10) Cascade","4.81%","5","104","97","11494","1.12e-2","5.48e-2","5.70","1.00e+0","4.24e-2","1.84e-3"
"REACTOME_PATHWAY","Toll Like Receptor 5 (TLR5) Cascade","4.81%","5","104","97","11494","1.12e-2","5.48e-2","5.70","1.00e+0","4.24e-2","1.84e-3"
"REACTOME_PATHWAY","Interferon gamma signaling","4.81%","5","104","97","11494","1.12e-2","5.48e-2","5.70","1.00e+0","4.24e-2","1.84e-3"
"REACTOME_PATHWAY","MyD88 cascade initiated on plasma membrane","4.81%","5","104","97","11494","1.12e-2","5.48e-2","5.70","1.00e+0","4.24e-2","1.84e-3"
"REACTOME_PATHWAY","Signaling by EGFR","3.85%","4","104","53","11494","1.18e-2","5.79e-2","8.34","1.00e+0","4.48e-2","1.32e-3"
"REACTOME_PATHWAY","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","2.88%","3","104","19","11494","1.23e-2","5.88e-2","17.45","1.00e+0","4.55e-2","6.28e-4"
"REACTOME_PATHWAY","Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants","2.88%","3","104","19","11494","1.23e-2","5.88e-2","17.45","1.00e+0","4.55e-2","6.28e-4"
"REACTOME_PATHWAY","Regulation of MITF-M-dependent genes involved in cell cycle and proliferation","2.88%","3","104","19","11494","1.23e-2","5.88e-2","17.45","1.00e+0","4.55e-2","6.28e-4"
"REACTOME_PATHWAY","Signaling by Ligand-Responsive EGFR Variants in Cancer","2.88%","3","104","19","11494","1.23e-2","5.88e-2","17.45","1.00e+0","4.55e-2","6.28e-4"
"REACTOME_PATHWAY","Signaling by KIT in disease","2.88%","3","104","19","11494","1.23e-2","5.88e-2","17.45","1.00e+0","4.55e-2","6.28e-4"
"REACTOME_PATHWAY","Neuronal System","9.62%","10","104","420","11494","1.30e-2","6.15e-2","2.63","1.00e+0","4.76e-2","4.66e-3"
"REACTOME_PATHWAY","Intrinsic Pathway for Apoptosis","3.85%","4","104","55","11494","1.31e-2","6.16e-2","8.04","1.00e+0","4.76e-2","1.51e-3"
"REACTOME_PATHWAY","Synthesis of PIPs at the plasma membrane","3.85%","4","104","55","11494","1.31e-2","6.16e-2","8.04","1.00e+0","4.76e-2","1.51e-3"
"REACTOME_PATHWAY","Signaling by PDGFR in disease","2.88%","3","104","20","11494","1.36e-2","6.31e-2","16.58","1.00e+0","4.88e-2","7.33e-4"
"REACTOME_PATHWAY","Diseases of hemostasis","2.88%","3","104","20","11494","1.36e-2","6.31e-2","16.58","1.00e+0","4.88e-2","7.33e-4"
"REACTOME_PATHWAY","Co-inhibition by CTLA4","2.88%","3","104","20","11494","1.36e-2","6.31e-2","16.58","1.00e+0","4.88e-2","7.33e-4"
"REACTOME_PATHWAY","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","4.81%","5","104","103","11494","1.37e-2","6.31e-2","5.37","1.00e+0","4.88e-2","2.39e-3"
"REACTOME_PATHWAY","MyD88 dependent cascade initiated on endosome","4.81%","5","104","104","11494","1.41e-2","6.46e-2","5.31","1.00e+0","5.00e-2","2.49e-3"
"REACTOME_PATHWAY","MITF-M-dependent gene expression","4.81%","5","104","104","11494","1.41e-2","6.46e-2","5.31","1.00e+0","5.00e-2","2.49e-3"
"REACTOME_PATHWAY","Toll Like Receptor 3 (TLR3) Cascade","4.81%","5","104","106","11494","1.50e-2","6.82e-2","5.21","1.00e+0","5.27e-2","2.71e-3"
"REACTOME_PATHWAY","Signaling by PDGF","3.85%","4","104","58","11494","1.51e-2","6.82e-2","7.62","1.00e+0","5.27e-2","1.84e-3"
"REACTOME_PATHWAY","Signaling by ERBB4","3.85%","4","104","58","11494","1.51e-2","6.82e-2","7.62","1.00e+0","5.27e-2","1.84e-3"
"REACTOME_PATHWAY","Toll Like Receptor 7/8 (TLR7/8) Cascade","4.81%","5","104","108","11494","1.60e-2","7.20e-2","5.12","1.00e+0","5.57e-2","2.94e-3"
"REACTOME_PATHWAY","NPAS4 regulates expression of target genes","2.88%","3","104","22","11494","1.63e-2","7.28e-2","15.07","1.00e+0","5.63e-2","9.78e-4"
"REACTOME_PATHWAY","Regulation of signaling by CBL","2.88%","3","104","22","11494","1.63e-2","7.28e-2","15.07","1.00e+0","5.63e-2","9.78e-4"
"REACTOME_PATHWAY","Interleukin-12 family signaling","3.85%","4","104","60","11494","1.65e-2","7.33e-2","7.37","1.00e+0","5.67e-2","2.09e-3"
"REACTOME_PATHWAY","Nuclear Events (kinase and transcription factor activation)","3.85%","4","104","61","11494","1.73e-2","7.63e-2","7.25","1.00e+0","5.90e-2","2.22e-3"
"REACTOME_PATHWAY","Toll Like Receptor 9 (TLR9) Cascade","4.81%","5","104","111","11494","1.75e-2","7.64e-2","4.98","1.00e+0","5.91e-2","3.31e-3"
"REACTOME_PATHWAY","Parasitic Infection Pathways","6.73%","7","104","231","11494","1.75e-2","7.64e-2","3.35","1.00e+0","5.91e-2","4.93e-3"
"REACTOME_PATHWAY","Leishmania infection","6.73%","7","104","231","11494","1.75e-2","7.64e-2","3.35","1.00e+0","5.91e-2","4.93e-3"
"REACTOME_PATHWAY","Signaling by NTRK2 (TRKB)","2.88%","3","104","23","11494","1.78e-2","7.69e-2","14.42","1.00e+0","5.94e-2","1.12e-3"
"REACTOME_PATHWAY","Nitric oxide stimulates guanylate cyclase","2.88%","3","104","23","11494","1.78e-2","7.69e-2","14.42","1.00e+0","5.94e-2","1.12e-3"
"REACTOME_PATHWAY","KEAP1-NFE2L2 pathway","4.81%","5","104","112","11494","1.81e-2","7.77e-2","4.93","1.00e+0","6.01e-2","3.44e-3"
"REACTOME_PATHWAY","Response of Mtb to phagocytosis","2.88%","3","104","24","11494","1.93e-2","8.26e-2","13.81","1.00e+0","6.39e-2","1.27e-3"
"REACTOME_PATHWAY","Transcriptional Regulation by MECP2","3.85%","4","104","64","11494","1.96e-2","8.36e-2","6.91","1.00e+0","6.47e-2","2.65e-3"
"REACTOME_PATHWAY","Signaling by EGFR in Cancer","2.88%","3","104","25","11494","2.09e-2","8.72e-2","13.26","1.00e+0","6.74e-2","1.43e-3"
"REACTOME_PATHWAY","Inactivation of CSF3 (G-CSF) signaling","2.88%","3","104","25","11494","2.09e-2","8.72e-2","13.26","1.00e+0","6.74e-2","1.43e-3"
"REACTOME_PATHWAY","Signaling by ERBB2 KD Mutants","2.88%","3","104","25","11494","2.09e-2","8.72e-2","13.26","1.00e+0","6.74e-2","1.43e-3"
"REACTOME_PATHWAY","Intrinsic Pathway of Fibrin Clot Formation","2.88%","3","104","25","11494","2.09e-2","8.72e-2","13.26","1.00e+0","6.74e-2","1.43e-3"
"REACTOME_PATHWAY","Fatty acid metabolism","5.77%","6","104","176","11494","2.09e-2","8.72e-2","3.77","1.00e+0","6.74e-2","5.21e-3"
"REACTOME_PATHWAY","Semaphorin interactions","3.85%","4","104","66","11494","2.13e-2","8.84e-2","6.70","1.00e+0","6.84e-2","2.97e-3"
"REACTOME_PATHWAY","Signaling by ERBB2 in Cancer","2.88%","3","104","26","11494","2.25e-2","9.18e-2","12.75","1.00e+0","7.10e-2","1.61e-3"
"REACTOME_PATHWAY","Growth hormone receptor signaling","2.88%","3","104","26","11494","2.25e-2","9.18e-2","12.75","1.00e+0","7.10e-2","1.61e-3"
"REACTOME_PATHWAY","Xenobiotics","2.88%","3","104","26","11494","2.25e-2","9.18e-2","12.75","1.00e+0","7.10e-2","1.61e-3"
"REACTOME_PATHWAY","Regulation of IFNA/IFNB signaling","2.88%","3","104","26","11494","2.25e-2","9.18e-2","12.75","1.00e+0","7.10e-2","1.61e-3"
"REACTOME_PATHWAY","Respiratory Syncytial Virus Infection Pathway","4.81%","5","104","120","11494","2.26e-2","9.22e-2","4.60","1.00e+0","7.13e-2","4.61e-3"
"REACTOME_PATHWAY","SUMO E3 ligases SUMOylate target proteins","5.77%","6","104","181","11494","2.33e-2","9.42e-2","3.66","1.00e+0","7.29e-2","5.96e-3"
"REACTOME_PATHWAY","Leishmania phagocytosis","4.81%","5","104","125","11494","2.58e-2","1.02e-1","4.42","1.00e+0","7.91e-2","5.48e-3"
"REACTOME_PATHWAY","Parasite infection","4.81%","5","104","125","11494","2.58e-2","1.02e-1","4.42","1.00e+0","7.91e-2","5.48e-3"
"REACTOME_PATHWAY","FCGR3A-mediated phagocytosis","4.81%","5","104","125","11494","2.58e-2","1.02e-1","4.42","1.00e+0","7.91e-2","5.48e-3"
"REACTOME_PATHWAY","FLT3 signaling in disease","2.88%","3","104","28","11494","2.58e-2","1.02e-1","11.84","1.00e+0","7.91e-2","2.00e-3"
"REACTOME_PATHWAY","Synthesis of PC","2.88%","3","104","28","11494","2.58e-2","1.02e-1","11.84","1.00e+0","7.91e-2","2.00e-3"
"REACTOME_PATHWAY","Infection with Mycobacterium tuberculosis","2.88%","3","104","28","11494","2.58e-2","1.02e-1","11.84","1.00e+0","7.91e-2","2.00e-3"
"REACTOME_PATHWAY","SUMOylation","5.77%","6","104","187","11494","2.63e-2","1.04e-1","3.55","1.00e+0","8.02e-2","6.96e-3"
"REACTOME_PATHWAY","Serotonin clearance from the synaptic cleft","1.92%","2","104","3","11494","2.66e-2","1.04e-1","73.68","1.00e+0","8.06e-2","2.42e-4"
"REACTOME_PATHWAY","Defective factor XII causes hereditary angioedema","1.92%","2","104","3","11494","2.66e-2","1.04e-1","73.68","1.00e+0","8.06e-2","2.42e-4"
"REACTOME_PATHWAY","Downregulation of ERBB2 signaling","2.88%","3","104","29","11494","2.76e-2","1.07e-1","11.43","1.00e+0","8.31e-2","2.22e-3"
"REACTOME_PATHWAY","Viral Infection Pathways","14.42%","15","104","895","11494","2.83e-2","1.10e-1","1.85","1.00e+0","8.50e-2","1.45e-2"
"REACTOME_PATHWAY","AURKA Activation by TPX2","3.85%","4","104","74","11494","2.86e-2","1.11e-1","5.97","1.00e+0","8.56e-2","4.48e-3"
"REACTOME_PATHWAY","MET activates PTK2 signaling","2.88%","3","104","31","11494","3.12e-2","1.20e-1","10.70","1.00e+0","9.26e-2","2.69e-3"
"REACTOME_PATHWAY","Thrombin signalling through proteinase activated receptors (PARs)","2.88%","3","104","31","11494","3.12e-2","1.20e-1","10.70","1.00e+0","9.26e-2","2.69e-3"
"REACTOME_PATHWAY","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3.85%","4","104","78","11494","3.28e-2","1.25e-1","5.67","1.00e+0","9.68e-2","5.40e-3"
"REACTOME_PATHWAY","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2.88%","3","104","32","11494","3.31e-2","1.26e-1","10.36","1.00e+0","9.72e-2","2.95e-3"
"REACTOME_PATHWAY","Cellular response to chemical stress","5.77%","6","104","199","11494","3.32e-2","1.26e-1","3.33","1.00e+0","9.72e-2","9.32e-3"
"REACTOME_PATHWAY","DNA Double Strand Break Response","3.85%","4","104","79","11494","3.38e-2","1.28e-1","5.60","1.00e+0","9.88e-2","5.65e-3"
"REACTOME_PATHWAY","Signaling by MAP2K mutants","1.92%","2","104","4","11494","3.54e-2","1.33e-1","55.26","1.00e+0","1.03e-1","4.81e-4"
"REACTOME_PATHWAY","Mitotic G1 phase and G1/S transition","4.81%","5","104","139","11494","3.61e-2","1.35e-1","3.98","1.00e+0","1.05e-1","8.51e-3"
"REACTOME_PATHWAY","Transcriptional Regulation by NPAS4","2.88%","3","104","34","11494","3.70e-2","1.38e-1","9.75","1.00e+0","1.07e-1","3.51e-3"
"REACTOME_PATHWAY","Metabolic disorders of biological oxidation enzymes","2.88%","3","104","35","11494","3.91e-2","1.45e-1","9.47","1.00e+0","1.12e-1","3.82e-3"
"REACTOME_PATHWAY","PI Metabolism","3.85%","4","104","85","11494","4.07e-2","1.51e-1","5.20","1.00e+0","1.17e-1","7.31e-3"
"REACTOME_PATHWAY","RAF activation","2.88%","3","104","36","11494","4.11e-2","1.52e-1","9.21","1.00e+0","1.17e-1","4.14e-3"
"REACTOME_PATHWAY","Macroautophagy","4.81%","5","104","145","11494","4.12e-2","1.52e-1","3.81","1.00e+0","1.17e-1","1.01e-2"
"REACTOME_PATHWAY","Post NMDA receptor activation events","3.85%","4","104","87","11494","4.31e-2","1.58e-1","5.08","1.00e+0","1.22e-1","7.93e-3"
"REACTOME_PATHWAY","HDR through Single Strand Annealing (SSA)","2.88%","3","104","37","11494","4.32e-2","1.58e-1","8.96","1.00e+0","1.22e-1","4.47e-3"
"REACTOME_PATHWAY","Signalling to p38 via RIT and RIN","1.92%","2","104","5","11494","4.40e-2","1.59e-1","44.21","1.00e+0","1.23e-1","7.97e-4"
"REACTOME_PATHWAY","NGF-independant TRKA activation","1.92%","2","104","5","11494","4.40e-2","1.59e-1","44.21","1.00e+0","1.23e-1","7.97e-4"
"REACTOME_PATHWAY","Dopamine clearance from the synaptic cleft","1.92%","2","104","5","11494","4.40e-2","1.59e-1","44.21","1.00e+0","1.23e-1","7.97e-4"
"REACTOME_PATHWAY","Regulation of PLK1 Activity at G2/M Transition","3.85%","4","104","88","11494","4.44e-2","1.59e-1","5.02","1.00e+0","1.23e-1","8.25e-3"
"REACTOME_PATHWAY","Peptide hormone metabolism","3.85%","4","104","88","11494","4.44e-2","1.59e-1","5.02","1.00e+0","1.23e-1","8.25e-3"
"REACTOME_PATHWAY","Platelet Aggregation (Plug Formation)","2.88%","3","104","39","11494","4.75e-2","1.70e-1","8.50","1.00e+0","1.31e-1","5.19e-3"
"REACTOME_PATHWAY","Cell-Cell communication","4.81%","5","104","153","11494","4.85e-2","1.73e-1","3.61","1.00e+0","1.34e-1","1.25e-2"
"REACTOME_PATHWAY","FCERI mediated MAPK activation","3.85%","4","104","94","11494","5.22e-2","1.82e-1","4.70","1.00e+0","1.41e-1","1.04e-2"
"REACTOME_PATHWAY","SARS-CoV-2 Infection","6.73%","7","104","300","11494","5.26e-2","1.82e-1","2.58","1.00e+0","1.41e-1","1.90e-2"
"REACTOME_PATHWAY","FLT3 signaling through SRC family kinases","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","Activation of TRKA receptors","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","Estrogen-stimulated signaling through PRKCZ","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","Activated NTRK3 signals through PI3K","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","Extrinsic Pathway of Fibrin Clot Formation","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","MET activates PTPN11","1.92%","2","104","6","11494","5.26e-2","1.82e-1","36.84","1.00e+0","1.41e-1","1.19e-3"
"REACTOME_PATHWAY","MET promotes cell motility","2.88%","3","104","42","11494","5.43e-2","1.87e-1","7.89","1.00e+0","1.45e-1","6.40e-3"
"REACTOME_PATHWAY","Autophagy","4.81%","5","104","160","11494","5.55e-2","1.91e-1","3.45","1.00e+0","1.47e-1","1.50e-2"
"REACTOME_PATHWAY","Negative regulation of MAPK pathway","2.88%","3","104","43","11494","5.66e-2","1.94e-1","7.71","1.00e+0","1.50e-1","6.83e-3"
"REACTOME_PATHWAY","Netrin-1 signaling","2.88%","3","104","44","11494","5.90e-2","2.01e-1","7.54","1.00e+0","1.56e-1","7.28e-3"
"REACTOME_PATHWAY","Activation of NMDA receptors and postsynaptic events","3.85%","4","104","100","11494","6.06e-2","2.05e-1","4.42","1.00e+0","1.58e-1","1.28e-2"
"REACTOME_PATHWAY","MET activates PI3K/AKT signaling","1.92%","2","104","7","11494","6.11e-2","2.05e-1","31.58","1.00e+0","1.58e-1","1.65e-3"
"REACTOME_PATHWAY","ARMS-mediated activation","1.92%","2","104","7","11494","6.11e-2","2.05e-1","31.58","1.00e+0","1.58e-1","1.65e-3"
"REACTOME_PATHWAY","STAT5 Activation","1.92%","2","104","7","11494","6.11e-2","2.05e-1","31.58","1.00e+0","1.58e-1","1.65e-3"
"REACTOME_PATHWAY","Biosynthesis of maresin-like SPMs","1.92%","2","104","7","11494","6.11e-2","2.05e-1","31.58","1.00e+0","1.58e-1","1.65e-3"
"REACTOME_PATHWAY","Apoptosis","4.81%","5","104","166","11494","6.19e-2","2.07e-1","3.33","1.00e+0","1.60e-1","1.73e-2"
"REACTOME_PATHWAY","Cyclin D associated events in G1","2.88%","3","104","46","11494","6.38e-2","2.12e-1","7.21","1.00e+0","1.64e-1","8.24e-3"
"REACTOME_PATHWAY","G1 Phase","2.88%","3","104","46","11494","6.38e-2","2.12e-1","7.21","1.00e+0","1.64e-1","8.24e-3"
"REACTOME_PATHWAY","Netrin mediated repulsion signals","1.92%","2","104","8","11494","6.95e-2","2.29e-1","27.63","1.00e+0","1.77e-1","2.19e-3"
"REACTOME_PATHWAY","Defective factor VIII causes hemophilia A","1.92%","2","104","8","11494","6.95e-2","2.29e-1","27.63","1.00e+0","1.77e-1","2.19e-3"
"REACTOME_PATHWAY","G alpha (i) signalling events","6.73%","7","104","324","11494","7.08e-2","2.33e-1","2.39","1.00e+0","1.80e-1","2.75e-2"
"REACTOME_PATHWAY","Metabolism","25.96%","27","104","2197","11494","7.51e-2","2.46e-1","1.36","1.00e+0","1.90e-1","5.24e-2"
"REACTOME_PATHWAY","Interleukin-23 signaling","1.92%","2","104","9","11494","7.78e-2","2.53e-1","24.56","1.00e+0","1.96e-1","2.80e-3"
"REACTOME_PATHWAY","Interleukin-9 signaling","1.92%","2","104","9","11494","7.78e-2","2.53e-1","24.56","1.00e+0","1.96e-1","2.80e-3"
"REACTOME_PATHWAY","Senescence-Associated Secretory Phenotype (SASP)","3.85%","4","104","113","11494","8.09e-2","2.62e-1","3.91","1.00e+0","2.03e-1","1.92e-2"
"REACTOME_PATHWAY","p53-Dependent G1/S DNA damage checkpoint","2.88%","3","104","53","11494","8.16e-2","2.63e-1","6.26","1.00e+0","2.04e-1","1.22e-2"
"REACTOME_PATHWAY","p53-Dependent G1 DNA Damage Response","2.88%","3","104","53","11494","8.16e-2","2.63e-1","6.26","1.00e+0","2.04e-1","1.22e-2"
"REACTOME_PATHWAY","Drug ADME","3.85%","4","104","114","11494","8.26e-2","2.65e-1","3.88","1.00e+0","2.05e-1","1.98e-2"
"REACTOME_PATHWAY","DNA Repair","6.73%","7","104","338","11494","8.29e-2","2.66e-1","2.29","1.00e+0","2.05e-1","3.35e-2"
"REACTOME_PATHWAY","TCR signaling","3.85%","4","104","115","11494","8.42e-2","2.69e-1","3.84","1.00e+0","2.08e-1","2.03e-2"
"REACTOME_PATHWAY","Signaling by Leptin","1.92%","2","104","10","11494","8.61e-2","2.71e-1","22.10","1.00e+0","2.10e-1","3.48e-3"
"REACTOME_PATHWAY","Signal attenuation","1.92%","2","104","10","11494","8.61e-2","2.71e-1","22.10","1.00e+0","2.10e-1","3.48e-3"
"REACTOME_PATHWAY","Interleukin-21 signaling","1.92%","2","104","10","11494","8.61e-2","2.71e-1","22.10","1.00e+0","2.10e-1","3.48e-3"
"REACTOME_PATHWAY","STAT5 activation downstream of FLT3 ITD mutants","1.92%","2","104","10","11494","8.61e-2","2.71e-1","22.10","1.00e+0","2.10e-1","3.48e-3"
"REACTOME_PATHWAY","G1/S DNA Damage Checkpoints","2.88%","3","104","55","11494","8.70e-2","2.73e-1","6.03","1.00e+0","2.11e-1","1.34e-2"
"REACTOME_PATHWAY","G2/M Transition","4.81%","5","104","188","11494","8.84e-2","2.77e-1","2.94","1.00e+0","2.14e-1","2.78e-2"
"REACTOME_PATHWAY","Mitotic G2-G2/M phases","4.81%","5","104","190","11494","9.11e-2","2.84e-1","2.91","1.00e+0","2.20e-1","2.90e-2"
"REACTOME_PATHWAY","Regulation of the apoptosome activity","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"
"REACTOME_PATHWAY","Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"
"REACTOME_PATHWAY","Signaling by LTK","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"
"REACTOME_PATHWAY","Maturation of nucleoprotein","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"
"REACTOME_PATHWAY","Formation of apoptosome","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"
"REACTOME_PATHWAY","PECAM1 interactions","1.92%","2","104","11","11494","9.43e-2","2.89e-1","20.09","1.00e+0","2.24e-1","4.23e-3"

